JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

A3729 PJ34

Target: PARP

Summary: PARP-l inhibitor

≥50.9 mg/mL
A4163 UPF 1069

Target: PARP

Summary: Selective PARP2 inhibitor

insoluble in H2O; ≥12.7 mg/mL
A4084 Vorinostat (SAHA, MK0683)

9 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
A4089 Mocetinostat (MGCD0103, MG0103)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,isotype-selective and potent

insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
A4501 Tubacin

3 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable

insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
A4096 Belinostat (PXD101)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL
A4101 Tubastatin A

6 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
A1912 Lomeguatrib

Target: O6-methylguanine-DNA-methyl-transferase (MGMT)

Summary: MGMT inhibitor

≥50 mg/mL
A8547 Tubastatin A HCl

1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; ≥12.34 mg/mL
A8183 Trichostatin A (TSA)

13 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; ≥15.12 mg/mL